WO2023170177 - FUSION POLYPEPTIDES WITH DEAMIDASE INHIBITOR AND DEAMIDASE DOMAINS
National phase entry:
Publication Number
WO/2023/170177
Publication Date
14.09.2023
International Application No.
PCT/EP2023/055936
International Filing Date
08.03.2023
Title **
[English]
FUSION POLYPEPTIDES WITH DEAMIDASE INHIBITOR AND DEAMIDASE DOMAINS
[French]
POLYPEPTIDES DE FUSION À DOMAINES DÉSAMIDASE ET INHIBITEURS DE DÉSAMIDASE
Applicants **
NOVOZYMES A/S
Krogshoejvej 36
2880 Bagsvaerd, DK
Inventors
EKLOEF, Jens Magnus
Krogshoejvej 36
2880 Bagsvaerd, DK
Priority Data
22160942.3
08.03.2022
EP
22183793.3
08.07.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1449 | |
| EPO | Filing, Examination | 5355 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 3310 |
Total: 11310 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to polypeptides having deamidase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.[French]
La présente invention concerne des polypeptides ayant une activité désamidase et des polynucléotides codant les polypeptides. L'invention concerne également des constructions d'acide nucléique, des vecteurs et des cellules hôtes comprenant les polynucléotides ainsi que des procédés de production et d'utilisation des polypeptides.